XMTR Stock Cash Flow Statements

Xometry Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Xometry Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30

cash flows from operating activities:
net income	-26,437,000	-15,076,000	-9,896,000	-10,199,000	-13,704,000	-16,604,000	-10,553,000	-12,010,000	-26,559,000	-18,343,000	-24,424,000	-15,041,000	-16,549,000	-19,995,000	-23,905,000	-14,711,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	4,495,000	4,246,000	3,390,000	3,213,000	3,256,000	3,153,000	2,799,000	2,478,000	2,895,000	2,566,000	2,103,000	1,909,000	2,008,000	1,799,000	1,292,000	817,000
reduction in carrying amount of right-of-use asset	1,112,000	1,100,000	1,130,000	1,126,000	1,106,000	1,096,000	1,098,000	1,078,000	10,244,000	1,935,000	1,885,000	1,811,000	1,775,000	1,765,000	144,000	369,000
lease termination	0	-30,000
stock-based compensation	7,895,000	7,342,000
revaluation of contingent consideration			0	0	0	137,000	266,000	118,000			383,000	0	0	434,000
income from unconsolidated joint venture	0	-90,000		-51,000	55,000	-97,000		66,000	-137,000	-66,000		3,000	-69,000	-34,000
donation of common stock	614,000	516,000	623,000	406,000	314,000	343,000	333,000	326,000	0	370,000	0	987,000			1,069,000
loss on debt extinguishment															0
gain on sale of property and equipment
amortization of deferred costs on convertible notes	472,000	465,000	465,000	464,000	466,000	464,000	464,000	466,000	464,000	466,000	468,000	469,000	469,000	312,000
deferred tax benefit
changes in other assets and liabilities:
accounts receivable	-147,000	-13,358,000	2,514,000	-6,970,000	-1,825,000	532,000	-5,721,000	-6,565,000	-5,504,000	-2,804,000	2,109,000	-7,199,000	-5,688,000	-6,145,000	-472,000	-3,771,000
inventory	-531,000	-41,000	-684,000	-565,000	7,000	-40,000	-1,533,000	-22,000	-128,000	133,000	4,031,000	-3,952,000	452,000	-180,000	-549,000	64,000
prepaid expenses	1,401,000	-1,519,000	-187,000	1,281,000	-62,000	-433,000	-666,000	918,000	1,232,000	185,000	168,000	-135,000	-2,216,000	567,000	55,000	1,190,000
other assets	1,936,000	-1,995,000	-141,000	1,761,000	3,035,000	-442,000	-1,475,000	3,941,000	1,141,000	-3,687,000	-3,094,000	-61,000	-3,499,000	-362,000	-263,000	80,000
accounts payable and accrued cost of revenue	-8,687,000	15,048,000
other accrued expenses	2,534,000	-540,000
contract liabilities	173,000	1,877,000	-235,000	-803,000	-558,000	2,277,000	-2,582,000	-292,000	34,000	1,436,000	-2,262,000	-85,000	717,000	2,145,000	-2,678,000	-862,000
lease liabilities	-1,639,000	-1,531,000	-1,843,000	-1,697,000	-1,700,000	-1,671,000	-1,675,000	-1,476,000	-1,399,000	-970,000	-1,508,000	-1,446,000	-1,404,000	-1,369,000	72,000	-383,000
other liabilities	-9,000	-13,000	-2,000
income taxes payable	-16,000	-92,000	115,000	-466,000	-878,000	-276,000	-472,000			157,000
net cash from operating activities	-427,000	-3,691,000	9,085,000	-3,634,000	-9,101,000	-11,734,000	-1,294,000	-5,976,000	-6,152,000	-16,455,000	-17,065,000	-11,314,000	-9,937,000	-24,259,000	-31,201,000	-16,810,000
capex	-6,963,000	-5,499,000	-4,537,000	-4,810,000	-4,403,000	-4,347,000	-6,423,000	-3,571,000	-4,306,000	-4,108,000	-4,042,000	-4,172,000	-2,893,000	-2,543,000	-1,637,000	-1,746,000
free cash flows	-7,390,000	-9,190,000	4,548,000	-8,444,000	-13,504,000	-16,081,000	-7,717,000	-9,547,000	-10,458,000	-20,563,000	-21,107,000	-15,486,000	-12,830,000	-26,802,000	-32,838,000	-18,556,000
cash flows from investing activities:
purchases of marketable securities	-2,167,000	-2,271,000	-2,498,000	-2,772,000	-10,755,000	-2,726,000	-2,952,000	-2,989,000
proceeds from sale of marketable securities	9,000,000	4,000,000	1,500,000	5,000,000	0	10,000,000	20,000,000	0			58,923,000	0	0	4,000
purchases of property and equipment	-6,963,000	-5,499,000	-4,537,000	-4,810,000	-4,403,000	-4,347,000	-6,423,000	-3,571,000	-4,306,000	-4,186,000	-4,042,000	-4,172,000	-2,893,000	-2,543,000	-1,637,000	-1,877,000
distributions in excess of earnings	-18,000	84,000
proceeds from sale of property and equipment			0	0			0	0	0	223,000	24,000	0	0	165,000
net cash from investing activities	-148,000	-3,686,000	-5,445,000	-2,594,000	-15,067,000	2,927,000	10,625,000	-6,560,000	22,741,000	-10,000,000	52,706,000	-5,510,000	-3,361,000	-282,465,000	58,855,000	-268,855,000
cash flows from financing activities:
proceeds from issuance of convertible notes											0	0	0	287,500,000
costs incurred in connection with issuance of convertible notes											0	0	-8,000	-9,301,000
payments for repurchase of convertible notes
purchase of capped calls
purchase of treasury stock
proceeds from stock options exercised	905,000	510,000	1,889,000	1,420,000	562,000	1,233,000	481,000	284,000	661,000	483,000	398,000	847,000	1,207,000	1,263,000	504,000	455,000
net cash from financing activities	1,536,000	510,000	1,424,000	1,420,000	562,000	1,233,000	-361,000	284,000	661,000	483,000	-534,000	847,000	1,199,000	279,460,000	858,000	306,108,000
effect of foreign currency translation on cash and cash equivalents	283,000	142,000	-262,000	167,000	-24,000	-149,000	81,000	-113,000	-217,000	15,000	58,000	-359,000	-37,000	-29,000	-28,000	-16,000
net decrease in cash and cash equivalents	1,244,000	-6,725,000	4,802,000	-4,641,000	-23,630,000	-7,723,000		-12,365,000	17,033,000	-25,957,000		-16,336,000	-12,136,000	-27,293,000
cash and cash equivalents at beginning of the period	0	22,232,000		0	0	53,424,000						0	0	86,262,000
cash and cash equivalents at end of the period	1,244,000	15,507,000		-4,641,000	-23,630,000	45,701,000		-12,365,000	17,033,000	39,705,000		-16,336,000	-12,136,000	58,969,000
supplemental cash flow information:
cash paid for interest	733,000	1,438,000	0	1,437,000	0	1,438,000	0	1,437,000	0	1,438,000	0				0	248,000
non-cash investing and financing activities:
non-cash purchase of property and equipment										78,000						131,000
non-cash consideration in connection with business combination	0	625,000					0	0	0	1,593,000
non-cash costs incurred in connection with the issuance of convertible notes
impairment of assets							0	151,000	219,000	27,000	380,000
(income) income from unconsolidated joint venture
losses on marketable securities
loss on sale of property and equipment							0	0	1,000	91,000	-24,000	0	0	71,000
inventory write-off							0	0
restructuring charges
cash paid for business combination, net of cash acquired							0	0	0	-3,349,000
payment of contingent consideration
payments on finance lease obligations											0	0	0	-2,000	-3,000	-3,000
cash and cash equivalents at beginning of the year							0	0	0	65,662,000
cash and cash equivalents at end of the year
stock based compensation				6,954,000	8,125,000	6,036,000	5,896,000	5,730,000	5,798,000	4,694,000	5,124,000	5,113,000	5,479,000	3,456,000	2,648,000	2,267,000
(gain) loss on sale of property and equipment				0
deferred taxes benefit				-15,000			-88,000	-22,000	-21,000	-23,000	-651,000	0	0	-2,000
accounts payable				-3,865,000	-3,779,000	-10,649,000	6,103,000	690,000	453,000	-503,000	25,000	-2,113,000	4,625,000	-2,752,000	5,615,000	-7,922,000
accrued expenses				5,263,000	-2,921,000	4,440,000	6,421,000	-1,711,000	4,862,000	-2,119,000	-5,188,000	7,632,000	802,000	-2,843,000	-15,939,000	4,384,000
non-cash interest expense															0	0
restructuring charge
proceeds from life insurance
proceeds from initial public offering, net of underwriters' discount															0
payments in connection with initial public offering															317,000	-3,471,000
repayment of term loan															0
proceeds from the exercise of warrants
net increase in cash and cash equivalents															28,484,000	20,427,000
shares issued in business combinations
non-cash income tax benefit												0	0	-559,000
purchase of marketable securities										-2,688,000	-2,199,000	-1,338,000	-468,000	-280,091,000	-489,000
loss (income) from unconsolidated joint venture
purchase of short-term investments
proceeds from short-term investments
cash paid for business combinations, net of cash acquired
proceeds from issuance of series a-2, series b, series c, series d and series e convertible preferred stock, net of issuance costs
repurchase of series a-2, series b, series c and series d convertible preferred stock
deemed dividend to preferred stockholders
proceeds from term loan
proceeds from other borrowings
repayment of other borrowings
non-cash consideration in connection with business combinations
unrealized loss on marketable securities												469,000	332,000	858,000	1,763,000
non-cash investing activity:
impairment of long-lived assets
non-cash financing activity:
non-cash amounts incurred in connection with initial public offering
deferred commissions														-1,425,000
impairment of goodwill and intangible assets
inventory write off
accretion of discount on short-term investments
payment on line of credit
cash and cash equivalents at beginning of period																0
cash and cash equivalents at end of period																20,427,000

We provide you with 20 years of cash flow statements for Xometry stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Xometry stock. Explore the full financial landscape of Xometry stock with our expertly curated income statements.

The information provided in this report about Xometry stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.